Universal Health Services (NYSE:UHS - Get Free Report) was upgraded by research analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a report released on Sunday.
A number of other analysts have also commented on the company. Weiss Ratings reaffirmed a "buy (b)" rating on shares of Universal Health Services in a research note on Monday, December 29th. Zacks Research lowered Universal Health Services from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 2nd. Cantor Fitzgerald decreased their price objective on Universal Health Services from $250.00 to $229.00 and set a "neutral" rating on the stock in a research note on Friday, February 27th. Barclays increased their price objective on Universal Health Services from $262.00 to $268.00 and gave the company an "overweight" rating in a research note on Thursday, February 26th. Finally, TD Cowen decreased their price objective on Universal Health Services from $251.00 to $245.00 and set a "buy" rating on the stock in a research note on Wednesday, January 7th. Six investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Universal Health Services currently has an average rating of "Hold" and a consensus price target of $232.21.
Read Our Latest Stock Analysis on Universal Health Services
Universal Health Services Stock Down 3.7%
UHS opened at $180.95 on Friday. The company has a quick ratio of 0.98, a current ratio of 1.05 and a debt-to-equity ratio of 0.55. The firm has a market cap of $11.05 billion, a P/E ratio of 7.82, a PEG ratio of 0.71 and a beta of 1.29. Universal Health Services has a 52 week low of $152.33 and a 52 week high of $246.32. The business's fifty day simple moving average is $201.62 and its 200 day simple moving average is $211.52.
Universal Health Services (NYSE:UHS - Get Free Report) last posted its quarterly earnings data on Wednesday, February 25th. The health services provider reported $5.88 EPS for the quarter, missing analysts' consensus estimates of $5.92 by ($0.04). The company had revenue of $4.49 billion for the quarter, compared to analyst estimates of $4.50 billion. Universal Health Services had a net margin of 8.57% and a return on equity of 19.65%. The firm's revenue was up 9.1% on a year-over-year basis. During the same period in the previous year, the business earned $4.92 EPS. Universal Health Services has set its FY 2026 guidance at 22.640-24.520 EPS. As a group, equities research analysts anticipate that Universal Health Services will post 15.92 EPS for the current fiscal year.
Institutional Trading of Universal Health Services
A number of hedge funds have recently added to or reduced their stakes in UHS. Elyxium Wealth LLC acquired a new stake in Universal Health Services in the 4th quarter worth about $25,000. SBI Securities Co. Ltd. raised its holdings in shares of Universal Health Services by 320.0% in the 3rd quarter. SBI Securities Co. Ltd. now owns 126 shares of the health services provider's stock worth $26,000 after purchasing an additional 96 shares during the period. Harbor Capital Advisors Inc. purchased a new position in shares of Universal Health Services in the 4th quarter worth about $26,000. Root Financial Partners LLC purchased a new position in shares of Universal Health Services in the 3rd quarter worth about $28,000. Finally, Founders Capital Management purchased a new position in shares of Universal Health Services in the 4th quarter worth about $28,000. 86.05% of the stock is owned by institutional investors and hedge funds.
About Universal Health Services
(
Get Free Report)
Universal Health Services, Inc NYSE: UHS is one of the largest diversified health care management companies in the United States, offering a broad spectrum of services through its acute care hospital and behavioral health segments. The company operates general acute care hospitals, surgical hospitals and ambulatory centers, as well as inpatient and outpatient behavioral health facilities. Its network provides emergency and specialized medicine, diagnostic imaging, laboratory services, advanced surgical care and rehabilitation, complemented by a comprehensive array of behavioral services including psychiatric treatment, addiction programs and developmental disabilities care.
In the acute care segment, UHS's facilities deliver services ranging from emergency department treatment and intensive care to maternity care and outpatient surgery.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Universal Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Universal Health Services wasn't on the list.
While Universal Health Services currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.